Thu.Jul 25, 2024

article thumbnail

Authors Beware of This Scam Macmillian Website

Plagiarism Today

Authors are constantly being targeted by fake publisher scams. Here we break down one such site and explain what to look for. The post Authors Beware of This Scam Macmillian Website appeared first on Plagiarism Today.

article thumbnail

If Z-Library Scam Did Deceive Millions, Exploiting a Lack of Research Was Ironic

TorrentFreak

In terms of general internet security, there are few things worse than reports of yet another potentially massive leak of personal information. Whether due to incompetence or deception, the bottom line is often the same; exploitation of data at the expense of those to whom it relates, and a further undermining of online safety to the detriment of all.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

3 Count: Mungo Jerry

Plagiarism Today

Jetflix defendants seek to have convictions tossed, Indian direct pulls his own film and Mungo Jerry frontman seeks to battle piracy. The post 3 Count: Mungo Jerry appeared first on Plagiarism Today.

article thumbnail

New Site Blocking Push Aims to Curb Italy’s Growing Stream-Ripping Numbers

TorrentFreak

Free music is easy to find nowadays. Just head over to YouTube and there are millions of tracks, including many of the most recent releases. The music industry earns billions of dollars through associated advertising but doesn’t like the fact that some people download the tracks for offline use. A blunt solution would be to remove all music from YouTube.

Music 78
article thumbnail

Software Composition Analysis: The New Armor for Your Cybersecurity

Speaker: Blackberry, OSS Consultants, & Revenera

Software is complex, which makes threats to the software supply chain more real every day. 64% of organizations have been impacted by a software supply chain attack and 60% of data breaches are due to unpatched software vulnerabilities. In the U.S. alone, cyber losses totaled $10.3 billion in 2022. All of these stats beg the question, “Do you know what’s in your software?

article thumbnail

The Rapid Rise of AI, in Five Charts

JD Supra Law

With remarkable speed, AI has evolved from an intriguing concept into a practical business tool that is drawing large investments and more regulatory oversight. The launch of generative AI (GenAI) tools in late 2022 helped fuel what had been a steady adoption of AI.

article thumbnail

Mid-Year Review: AI Lawsuit Developments in 2024

Copyright Alliance

The development and launch of new generative artificial intelligence (AI) technologies over the last two years has been revolutionary. But these advancements have been accompanied by significant concerns from copyright […] The post Mid-Year Review: AI Lawsuit Developments in 2024 appeared first on Copyright Alliance.

More Trending

article thumbnail

Book review: Enforcing Intellectual Property Rights

The IPKat

What better way to start the summer than by reading an intellectual property book. This time, this Kat had the opportunity to review Jane Lambert's book “ Enforcing Intellectual Property Rights: A Concise Guide for Businesses, Innovative and Creative Individuals ”, published earlier this year in its latest edition. Structure of the book The book is short, comprising 158 pages and divided into 12 chapters, each of which can be read independently if required.

article thumbnail

The U.S. Copyright Office’s Position on the Copyrightability of Works Made with the Assistance of Generative AI (Part One)

JD Supra Law

Since the release and popularization of platforms such as Midjourney and DALL-E, the past few years have seen a staggering proliferation of art made using text-to-image models—familiarly known as “AI art.” Tens of millions of images are created daily using generative AI, and, as time continues, it is becoming more and more difficult to distinguish between AI-generated art and human-created works.

Art 77
article thumbnail

Are You Better Off Today Than You Were Five Years Ago? Selected comments on the MLC Redesignation: Songwriters Guild of America, the Society of Composers & Lyricists, and Music Creators North America Joint Comment

The Trichordist

Songwriters Guild of America, the Society of Composers & Lyricists, and Music Creators North America filed a thoughtful and detailed comment that merits an equally thoughtful read.

Music 67
article thumbnail

Design Patent Trends at the ITC – Mid-Year Update

JD Supra Law

Ten Section 337 Investigations were terminated in the first half of 2024. Of those ten investigations, two involved design patents. Although those investigations ended with the Commission issuing no remedial orders (including two closely watched investigations that ultimately found no Section 337 violation), Section 337 investigations involving design patents continue to fare better at obtaining remedial orders than Section 337 investigations involving just utility patents or other unfair acts,

article thumbnail

IPO Diversity in Innovation Toolkit

Women and diverse employees have the technical skill and knowledge, yet their contributions are not patented at the same rate as those of their male counterparts.This toolkit can help organizations move the needle on achieving gender parity in innovation.

article thumbnail

Sustaining Opposition, TTAB Finds RYDE OUT Confusable with RYDE for Supplements and Energy Drinks

The TTABlog

Opposer British American Tobacco ("BAT") ran roughshod over Applicant Ruff Ryders' application to register the mark RYDE OUT for dietary and nutritional supplements and for energy drinks. The Board found confusion likely with BAT's mark RYDE for the same goods. Neither party claimed use of its mark, but BAT established priority based on the constructive first use date of its pending application, which claimed convention priority from a Jamaican application filed in September 2019.

article thumbnail

FDA Approves Second Soliris® (eculizumab) Interchangeable Biosimilar - Samsung Bioepis’s Epysqli® (eculizumab-aagh)

JD Supra Law

On July 19, 2024, the FDA approved the second biosimilar of Alexion / AstraZeneca’s Soliris® (eculizumab), Samsung Bioepis’s Epysqli® (eculizumab-aagh), approximately one year after Samsung Bioepis announced the FDA acceptance of its aBLA. Epysqli® was approved as an interchangeable.

68
article thumbnail

FinCEN CTA Update: New FAQs on BOI Reporting Requirements - Cogency Global

Cogency Global

What this is : The Corporate Transparency Act mandates that non-exempt reporting companies submit Beneficial Ownership Information (BOI) reports to FinCEN. Deadlines differ based on whether the company existed before January 1, 2024, or was formed/registered on or after that date. What this means : Up until now, the legal community has been puzzled about a dissolved reporting company's duty to file a BOI report, especially if it dissolves or initiates dissolution before the deadline.

article thumbnail

Make No Mistake: Patentee Held to Terminal Disclaimer that Referenced a Patent Incorrectly Identified by the Patent Office

JD Supra Law

A court in the Western District of Oklahoma dismissed a complaint as to one of the asserted patents where the patent included a terminal disclaimer stating that the patent would be enforceable only as long as it was co-owned with a reference patent that the PTO had misidentified. The court relied on the public notice function of the patent system to hold the plaintiff to the.

Patent 68
article thumbnail

Call Off Chicken Little: The Sky is Not Falling for Skinny Labeling After GSK v. Teva

IP Watchdog

Although Professors Sean Tu and Aaron Kesselheim have advocated for legislation to respond to the Federal Circuit’s 2021 opinion in GSK v. Teva, that case did not—as they assert—“threaten[] to nullify every skinny label carveout.” Rather, the Federal Circuit applied the unremarkable principle that generic drug manufacturers are obligated to ensure that their labeling and other representations do not induce infringement of an innovator’s method-of-use patents.

Patent 59
article thumbnail

Patent Case Summaries | Week Ending July 19, 2024

JD Supra Law

Miller Mendel, Inc. v. City of Anna, Texas, Nos. 2022-1753, -1999 (Fed. Cir. (E.D. Tex.) July 18, 2024). Opinion by Cunningham, joined by Moore and Stoll. Miller Mendel sued City of Anna, Texas for infringement of a patent relating to a software system for managing pre-employment background investigations. City moved for judgment on the pleadings, arguing that asserted claims 1, 5, and 15 are ineligible for patenting under 35 U.S.C. § 101.

Patent 65
article thumbnail

7-Eleven Settles TM Suit Against Seven Eleven Law Group

IP Law 360

7-Eleven Inc. and a Chicago-based law practice called Seven Eleven Law Group have settled the trademark complaint the convenience store chain filed in November, alleging the firm was infringing its mark and causing consumer confusion.

Law 59
article thumbnail

EDVA Upholds USPTO’s Calculation of Patent Term Adjustment

JD Supra Law

Under the patent laws, the term of a patent may be increased for delays by the U.S. Patent and Trademark Office (USPTO) during the application process. See 35 U.S.C. § 154(b)(1). Conversely, the USPTO can reduce a patent term adjustment to account for delays caused by the patent applicant. See 35 U.S.C. § 154(b)(2)(C). In particular, the length of a patent term adjustment can be reduced if the applicant fails to provide an application in “condition for examination” within eight months from the.

Patent 65
article thumbnail

Questions Linger About DTSA's Scope After Motorola Ruling

IP Law 360

The Seventh Circuit’s recent ruling in Motorola v. Hytera, which held that the Defend Trade Secrets Act applies extraterritorially, does not address whether an act that furthers misappropriation must be committed by the defendant in order to satisfy the law's extraterritoriality requirement, say Ilissa Samplin and Grace Hart at Gibson Dunn.

Law 59
article thumbnail

Charging Ahead: Grappling With the Characterisation of Fixed and Floating Charges

JD Supra Law

The characterisation of fixed and floating charges remains a complex area, not least with respect to new intangible asset types. The key distinction between a fixed and a floating charge is well established as a matter of English law.

Law 65
article thumbnail

Patent Filings Roundup: New Kaifi Cases Filed; Mixed Results in Meetrix IP IPRs

IP Watchdog

This week there was a slightly below average 22 new patent filings—all inter partes reviews (IPRs)—at the Patent Trials and Appeal Board (PTAB). Meanwhile, district courts saw an above-average 88 new patent filings. At the PTAB, Roku filed six IPRs challenging as many Anonymous Media Research Holdings LLC [associated with Anonymous Media Research, LLC] patents.

Patent 59
article thumbnail

Feeding and Generating AI Creates Patent Application Challenges

JD Supra Law

The explosion of artificial intelligence has raised some challenging questions in patent law, particularly with prior art, or the body of knowledge available prior to the filing of patent application. Two of the most pressing questions are whether disclosing information to AI can be considered a public disclosure and thus prior art, and whether AI-generated information constitutes prior art.

article thumbnail

Does the Indian Patent Office Rejection Order on E-Cigarettes Violate International Treaties?

SpicyIP

Right on the heels of Tejaswini’s post on the Indian Patent Office’s E-Cigarettes patent rejection order, we are pleased to bring to you this guest post by Bharathwaj Ramakrishnan assessing the viability of the argument that the rejection order’s rationale violated India’s international commitments. Bharathwaj is a 3rd year LLB Student at RGSOIPL, IIT Kharagpur and loves books and IP.

Patent 59
article thumbnail

A Cautionary Tale of Taking the Preliminary Injunction Gambit with Unclear Trade Secrets

JD Supra Law

Recently, the U.S. Court of Appeals for the Federal Circuit provided a cautionary tale for trade secret owners who seek preliminary relief against a competitor who hires its former employees but do not clearly articulate the trade secrets the owner seeks to protect.

62
article thumbnail

Trademark law and LinkedIn resumes: watch out?

43(B)log

Portkey Tech. PTE Ltd v. Venkateswaran, 2024 WL 3487735, No. 23-CV-5074 (JPO) (S.D.N.Y. Jul. 19, 2024) Another case that starkly shows the effects of trademark’s abandonment of any harm requirement, not to its benefit, where false advertising claims fail because alleged misstatements about the extent of the defendant’s past involvement with a company don’t do it any identifiable harm, but trademark claims succeed because something something affiliation.

article thumbnail

Clever Pleading Can’t Save Koss’s Patents from Issue Preclusion Invalidity

Patently-O

by Dennis Crouch Koss Corporation v. Bose Corporation , 22-2090 (Fed. Cir. July 19, 2024) In its final written decisions, the PTAB found a number of Koss patent claims invalid and Koss appealed to the Federal Circuit. In the end, though the appellate panel found the appeals moot because all the claims had been invalidated in parallel district court litigation.

Patent 57
article thumbnail

No copyright over simple colors and shapes used to annotate X-rays

43(B)log

Overjet, Inc. v. VideaHealth, Inc., 2024 WL 3480212, No. 24-cv-10446-ADB (D. Mass. Jul. 19, 2024) The court denied Overjet’s request for a preliminary injunction on copyright and false advertising claims, concluding that Overjet’s selection of colors and shapes for annotating dental x-rays was unlikely to be protected by copyright and that the literally false statements identified by Overjet had been removed, thus preventing a finding of irreparable harm.

article thumbnail

DC Panel Upholds FDA's Win Against Ipsen's Generics Suit

IP Law 360

A D.C. panel declined to revive Ipsen's challenge to regulators' refusal to classify its acromegaly drug as a biologic, which would have blocked generic versions of it, finding Thursday the drug's active ingredient doesn't meet the Food, Drug and Cosmetic Act's definition of a protein to be considered a biologic.

52
article thumbnail

"Pure Irish Butter" plausibly misleads as to absence of dangerous chemicals

43(B)log

Winans v. Ornua Foods North America Inc., F.Supp.3d -, 2024 WL 1741079, No. 2:23-cv-01198-FB-RML (E.D.N.Y. Apr. 23, 2024) Plaintiffs alleged that the presence of per- and polyfluoralkyl substances (“PFAS”) in Kerrygold butter made the use of “pure Irish butter” into false advertising under NY law. The court declined to dismiss the complaint. Additional background: “[I]n early 2023, in response to a New York state law banning PFAS in food packaging, Ornua issued a recall of the Kerrygold Butter P

article thumbnail

Fed. Circ. Backs Penn. Jury Invalidating Sherwin-Williams IP

IP Law 360

A Pennsylvania federal judge rightfully invalidated claims of several Sherwin-Williams Co. paint coating patents after a jury trial, and properly barred inconsistent assertions from the company, the Federal Circuit held Thursday.

IP 52
article thumbnail

“Oy”-verlawyered

Likelihood of Confusion

Originally posted 2011-06-30 18:35:59. Republished by Blog Post PromoterI am stepping in to be the token cultural conservative as a guest blogger at Overlawyered next week. That should be fun, right? You laugh. I’ll have you know they hardly deleted any of the posts from last time. The post “Oy”-verlawyered appeared first on LIKELIHOOD OF CONFUSION™.

article thumbnail

Pfizer Calls GSK Patents In COVID Vax Case Unenforceable

IP Law 360

Pfizer and BioNTech have fired back at GlaxoSmithKline's patent suit against them over the COVID-19 vaccine, saying GSK's patents are unenforceable because the company delayed in filing its applications and then crafted them to cover the blockbuster vaccine after it became available.

Patent 52
article thumbnail

CCC Launches Collective AI License

Velocity of Content

CCC has licensed this report from Outsell, Inc., with the right to distribute it for marketing and market education purposes. CCC did not commission this report as a fee-for-hire white paper nor did it have influence on the outcome of the report. Outsell’s fact-based research, analysis, and rankings and all aspects of our opinion were independently derived.

article thumbnail

Blue Bottle Won't Be Sanctioned Or Pay Atty Fees In TM Row

IP Law 360

Blue Bottle won't be sanctioned nor ordered to pay $1.15 million in fees for losing its trademark suit against a company selling "Blue Brew" brand accessories, with a California federal judge ruling Wednesday that its infringement claims weren't frivolous and that its likelihood of confusion argument was "rooted in good faith.

article thumbnail

Everything You Wanted to Know About the Moody v. NetChoice Supreme Court Opinion

Technology & Marketing Law Blog

Normally, when a major Internet Law development occurs, I write two posts. First, I write up a quick hit for the media. See my short statement on the Moody v. NetChoice. decision. I then follow up with a comprehensive blog post–often a 5k+ word post that can take me 20+ hours to write. In advance of the Moody ruling, the editors of the Cato Supreme Court Review asked me to submit a book chapter based on my inevitable comprehensive post.